Many studies have shown that HDAC inhibitors are beneficial in pre-clinical models in treating lung fibrosis; however the mechanisms are not defined, and no study has examined the effects of HDAC inhibitors on H4K16Ac in lung fibrosis 3, 40. The gene discussed is HDAC9; the disease is pulmonary fibrosis.